Clinical Study

Nrg Lu-002: Maintenance Systemic Therapy Versus Consolidative Sterotactic Body Radiation Therapy (Sbrt) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer (Nsclc): A Randomized Phase II/III Trial

Posted Date: Jun 17, 2019

  • Investigator: Emily Daugherty
  • Specialties: Cancer, Lung Cancer, Oncology, Radiation Oncology
  • Type of Study: Drug

To goal of this study is to evaluate the impact of adding LCT (local consolidative therapy) to maintenance systemic therapy versus maintenance systemic therapy alone on progression-free survival for patients with metastatic NSCLC with no evidence of progression and limited metastatic sites after first-line systemic therapy


To Be Eligible: Stage Iv Non-Small Cell Lung Cancer With 3 Or Less Areas Of Metastatic Cancer Spread Aged 18 Years Or Older


Lung Cancer, Metastatic, Radiation Therapy

For More Information:

Dr. Emily Daugherty, Md

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.